Terms: = Prostate cancer AND COX6C, P09669, 1345, ENSG00000164919
15 results:
1. The impact of previous inguinal mesh hernioplasty on oncological and patient-reported outcomes following radical prostatectomy.
Westhofen T; Bensel M; Schlenker B; Becker A; Stief CG; Kretschmer A; Buchner A
Prostate; 2023 Oct; 83(14):1313-1322. PubMed ID: 37394751
[TBL] [Abstract] [Full Text] [Related]
2. Digital rectal examination impact on PSA derivatives and prostate biopsy triggers: a contemporary study.
da Silva Junior MM; Capibaribe DM; Avilez ND; Jalalizadeh M; Dias LB; Laranja WW; Guimarães F; Simões FA; Alonso JCC; Rejowski RF; Cintra A; Reis LO
Int Urol Nephrol; 2022 Sep; 54(9):2117-2123. PubMed ID: 35789453
[TBL] [Abstract] [Full Text] [Related]
3. Post-MRI transrectal micro-ultrasonography of transition zone PI-RADS > 2 lesions for biopsy guidance.
Cornud F; Lefevre A; Camparo P; Barat M; Dumonceau O; Galiano M; Flam T; Soyer P; Barral M
Eur Radiol; 2022 Nov; 32(11):7504-7512. PubMed ID: 35451606
[TBL] [Abstract] [Full Text] [Related]
4. Detection of a second primary cancer in a 18F-fluorocholine PET/CT - multicentre retrospective analysis on a group of 1345 prostate cancer patients.
Cegla P; Scibisz-Dziedzic K; Witkowska K; Kubiak A; Wierzchoslawska E; Kycler W; Chrapko B; Czepczyński R
Nucl Med Rev Cent East Eur; 2022; 25(1):25-30. PubMed ID: 35137934
[TBL] [Abstract] [Full Text] [Related]
5. Decreased accuracy of the prostate cancer EAU risk group classification in the era of imaging-guided diagnostic pathway: proposal for a new classification based on MRI-targeted biopsies and early oncologic outcomes after surgery.
Ploussard G; Manceau C; Beauval JB; Lesourd M; Almeras C; Gautier JR; Loison G; Salin A; Soulié M; Tollon C; Malavaud B; Roumiguié M
World J Urol; 2020 Oct; 38(10):2493-2500. PubMed ID: 31838560
[TBL] [Abstract] [Full Text] [Related]
6. RelB Expression Determines the Differential Effects of Ascorbic Acid in Normal and cancer Cells.
Wei X; Xu Y; Xu FF; Chaiswing L; Schnell D; Noel T; Wang C; Chen J; St Clair DK; St Clair WH
Cancer Res; 2017 Mar; 77(6):1345-1356. PubMed ID: 28108513
[TBL] [Abstract] [Full Text] [Related]
7. Quality of life after cancer-How the extent of impairment is influenced by patient characteristics.
Peters E; Mendoza Schulz L; Reuss-Borst M
BMC Cancer; 2016 Oct; 16(1):787. PubMed ID: 27724890
[TBL] [Abstract] [Full Text] [Related]
8. Perinatal and childhood factors and risk of prostate cancer in adulthood: MCC-Spain case-control study.
Lope V; García-Esquinas E; Ruiz-Dominguez JM; LLorca J; Jiménez-Moleón JJ; Ruiz-Cerdá JL; Alguacil J; Tardón A; Dierssen-Sotos T; Tabernero Á; Mengual L; Kogevinas M; Aragonés N; Castaño-Vinyals G; Pollán M; Pérez-Gómez B
Cancer Epidemiol; 2016 Aug; 43():49-55. PubMed ID: 27391546
[TBL] [Abstract] [Full Text] [Related]
9. Neoadjuvant Chemotherapy Using Reduced-Dose Docetaxel Followed by Radical prostatectomy for Patients With Intermediate and High-Risk prostate cancer: A Single-Center Study.
Nosov A; Reva S; Petrov S; Mamijev E; Novikov R; Veliev E; Imkamp F; Tolkach Y; Moiseenko V
Prostate; 2016 Nov; 76(15):1345-52. PubMed ID: 26864707
[TBL] [Abstract] [Full Text] [Related]
10. The histone deacetylase inhibitor Entinostat enhances polymer-mediated transgene expression in cancer cell lines.
Elmer JJ; Christensen MD; Barua S; Lehrman J; Haynes KA; Rege K
Biotechnol Bioeng; 2016 Jun; 113(6):1345-1356. PubMed ID: 26614912
[TBL] [Abstract] [Full Text] [Related]
11. Glycemic index, glycemic load and cancer risk.
Hu J; La Vecchia C; Augustin LS; Negri E; de Groh M; Morrison H; Mery L;
Ann Oncol; 2013 Jan; 24(1):245-51. PubMed ID: 22831983
[TBL] [Abstract] [Full Text] [Related]
12. Dietary transfatty acids and cancer risk.
Hu J; La Vecchia C; de Groh M; Negri E; Morrison H; Mery L;
Eur J Cancer Prev; 2011 Nov; 20(6):530-8. PubMed ID: 21701388
[TBL] [Abstract] [Full Text] [Related]
13. Dietary cholesterol intake and cancer.
Hu J; La Vecchia C; de Groh M; Negri E; Morrison H; Mery L;
Ann Oncol; 2012 Feb; 23(2):491-500. PubMed ID: 21543628
[TBL] [Abstract] [Full Text] [Related]
14. Squamous cell carcinoma of the bladder: a clinicopathologic analysis of 45 cases.
Lagwinski N; Thomas A; Stephenson AJ; Campbell S; Hoschar AP; El-Gabry E; Dreicer R; Hansel DE
Am J Surg Pathol; 2007 Dec; 31(12):1777-87. PubMed ID: 18043032
[TBL] [Abstract] [Full Text] [Related]
15. Long term follow-up of mass screening for prostate carcinoma in men with initial prostate specific antigen levels of 4.0 ng/ml or less.
Ito K; Kubota Y; Yamamoto T; Suzuki K; Fukabori Y; Kurokawa K; Yamanaka H
Cancer; 2001 Feb; 91(4):744-51. PubMed ID: 11241242
[TBL] [Abstract] [Full Text] [Related]
